{"name": "ArQule",
 "permalink": "arqule",
 "crunchbase_url": "http://www.crunchbase.com/company/arqule",
 "homepage_url": "http://www.arqule.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "jcelebi@arqule.com",
 "phone_number": "781-994-0300",
 "description": "",
 "created_at": "Sat Jan 22 04:10:49 UTC 2011",
 "updated_at": "Fri Nov 11 04:45:14 UTC 2011",
 "overview": "\u003Cp\u003EArQule, Inc. is a clinical-stage biotechnology company engaged in the research and development of cancer therapeutics. The Company employs technologies, such as its ArQule Kinase Inhibitor Platform (AKIP) to design and develop drugs. The Company\u00e2\u20ac\u2122s product is ARQ 197, an orally administered inhibitor of the c-Met receptor tyrosine kinase. ARQ 197 is being evaluated as monotherapy and in combination therapy in a Phase II clinical development program that includes trials in Microphthalmia Transcription Factor (MiT) associated tumors, non-small cell lung cancer (NSCLC), pancreatic adenocarcinoma and hepatocellular carcinoma (HCC). The Company has licensed commercial rights to ARQ 197 for human cancer indications to Daiichi Sankyo Co., Ltd. (Daiichi Sankyo) in the United States, Europe, South America and the rest of the world, excluding Japan and certain other Asian countries, where it has licensed commercial rights to Kyowa Hakko Kirin Co., Ltd. (Kyowa Hakko Kirin). \u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       44],
      "assets/images/resized/0011/8506/118506v1-max-150x150.png"],
     [[175,
       52],
      "assets/images/resized/0011/8506/118506v1-max-250x250.png"],
     [[175,
       52],
      "assets/images/resized/0011/8506/118506v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Paolo",
      "last_name": "Pucci",
      "permalink": "paolo-pucci",
      "image": null}},
   {"is_past": false,
    "title": "President and CEO",
    "person":
     {"first_name": "Peter",
      "last_name": "S. Lawrence",
      "permalink": "peter-s-lawrence",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "19 Presidential Way",
    "address2": "",
    "zip_code": "01801",
    "city": "Woburn",
    "state_code": "MA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [{"description": "ArQule plans $40.5M stock offering",
    "stoned_year": 2011,
    "stoned_month": 1,
    "stoned_day": 20,
    "source_url": "http://www.masshightech.com/stories/2011/01/17/daily32-ArQule-plans-405M-stock-offering.html",
    "source_text": "",
    "source_description": "ArQule plans $40.5M stock offering",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "ArQule",
      "permalink": "arqule"}},
   {"description": "has closed a public offering of stock, bringing in $46.5 million after expenses, which was $6 million more than the company expected",
    "stoned_year": 2011,
    "stoned_month": 1,
    "stoned_day": 26,
    "source_url": "http://www.masshightech.com/stories/2011/01/24/daily29-Arqule-clears-6M-more-than-expected-in-stock-sale.html",
    "source_text": null,
    "source_description": "Arqule clears $6M more than expected in stock sale",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "ArQule",
      "permalink": "arqule"}},
   {"description": "Arqule clears $6M more than expected in stock sale",
    "stoned_year": 2011,
    "stoned_month": 1,
    "stoned_day": 26,
    "source_url": "http://www.masshightech.com/stories/2011/01/24/daily29-Arqule-clears-6M-more-than-expected-in-stock-sale.html",
    "source_text": "",
    "source_description": "Arqule clears $6M more than expected in stock sale",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "ArQule",
      "permalink": "arqule"}},
   {"description": "ArQule license deal with Daiichi could land $265M",
    "stoned_year": 2011,
    "stoned_month": 11,
    "stoned_day": 10,
    "source_url": "http://www.masshightech.com/stories/2011/11/07/daily30-ArQule-license-deal-with-Daiichi-could-land-265M.html",
    "source_text": "",
    "source_description": "ArQule license deal with Daiichi could land $265M",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "ArQule",
      "permalink": "arqule"}}],
 "ipo":
  {"valuation_amount": null,
   "valuation_currency_code": "USD",
   "pub_year": null,
   "pub_month": null,
   "pub_day": null,
   "stock_symbol": "NASDAQ:ARQL"},
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}